期刊文献+

琥珀酸脱氢酶缺陷型肾细胞癌的临床病理特征 被引量:1

Clinicopathological analysis of succinate dehydrogenase deficient renal cell carcinoma
下载PDF
导出
摘要 运用HE染色及免疫组织化学(immunohistochemistry,IHC)等方法分析3例琥珀酸脱氢酶缺陷型肾细胞癌(succinate dehydrogenase-deficient renal cell carcinoma,SDH-deficient RCC)的临床病理特征、免疫表型,并结合相关文献进行综合分析。在3例SDH缺陷型肾细胞癌患者中,男女均有发生,年龄22~48(平均39.33)岁,病变位于左肾1例,右肾2例。其中1例患者发生同一侧肾脏肿块2个,分别位于右肾上极和右肾下极。所有肿瘤大体边界清楚,无明确包膜,边缘呈推挤性生长,切面实性,均质,灰红或灰褐色。镜下观:肿瘤组织结构多样,呈巢状、小管状、腺泡状或实性结构,肿瘤细胞呈多边形或圆形,细胞界限不清楚,细胞质丰富,嗜酸性或透明,细胞质内可见空泡状或包涵体结构,并可见嗜酸性絮状物,细胞核圆形或卵圆形,核膜光滑规则,染色质细腻,核仁不明显,细胞核大小较一致,为低级别核;肿瘤周边可见正常肾小管或肾小球。IHC显示SDH亚单位B(SDHB)抗体表达缺失,肿块周边非肿瘤组织,包括肾小管、血管内皮细胞及炎症细胞均呈阳性表达。3例患者手术治疗后随访2~8个月,均存活。SDH缺陷型肾细胞癌具有典型的病理组织学细胞特征,确诊需要IHC标记证实。 The clinicopathological features and immunophenotype of 3 cases of succinate dehydrogenase deficient renal cell carcinoma(succinate dehydrogenase-deficient renal cell carcinoma,SDH-deficient RCC)were analyzed by HE staining and immunohistochemistry(IHC),and combined with relevant literatures.SDH-deficient renal cell carcinoma occurred both in men and women in 3 cases,with an average age of 39.33 years old,ranging from 22 to 48 years old.The lesion was located in the left kidney in 1 case and in the right kidney in 2 cases.One patient had two renal masses on the same side,located at the upper pole of the right kidney and the lower pole of the right kidney respectively.All tumors are generally well circumscribed,without definite capsule,with pushing growth at the margin,solid section,homogeneous,grayish red or grayish brown.Microscopically,the tumor tissue structure is diverse,with nests,small tubes,acini or solid structures.The tumor cells are polygonal or round,with unclear cell boundaries,abundant cytoplasm,eosinophilic or transparent,vacuolar or inclusion body structures in the cytoplasm.Eosinophilic flocs,round or oval nuclei,smooth and regular nuclear membrane,fine chromatin,inconspicuous nucleoli,and relatively consistent nuclear size as low-grade nuclei are also its presented characteristics.Normal renal tubules or glomeruli can be seen around the tumor.Immunohistochemistry showed that the expression of SDH subunit B(SDHB)antibody was absent,and the surroundings of the mass were non-tumor tissues.Moreover,renal tubules,vascular endothelial cells and inflammatory cells were all positive in expression.Three patients were followed up for 2 to 8 months after surgical treatment and all survived.SDHdeficient renal cell carcinoma has typical histopathological cell characteristics,and its diagnosis needs to be confirmed by immunohistochemical markers.
作者 王桃丽 曹云 陈栋良 WANG Taoli;CAO Yun;CHEN Dongliang(Department of Pathology,Zhuzhou Central Hospital,Zhuzhou Hunan 412007;Department of Pathology,Sun Yat-sen University Cancer Center,Guangzhou 510060,China)
出处 《临床与病理杂志》 2021年第1期233-239,共7页 Journal of Clinical and Pathological Research
关键词 肾细胞癌 SDH缺陷 诊断 鉴别诊断 免疫组织化学 renal cell carcinoma succinate dehydrogenase defects diagnosis differential diagnosis immunohistochemistry
  • 相关文献

参考文献3

二级参考文献17

  • 1Moch H, Humphrey P, Ulbright T, et al. WHO classification of tumours of the urinary system and male genital organ [ M 1. Lyon : IARC Press, 2016.
  • 2Srigley JR, Delahunt B, Eble JN, et al. The International Society of Urological Pathology (ISUP) vancouver classification of renal neoplasia[ J ]. Am J Surg Pathol, 2013,37 ( 10 ) : 1469-1489. DOI: 10. 1097/PAS. 0b013e318299f2dl.
  • 3Yakirevich E, Magi-Galluzzi C, Grada Z, et al. Cadherin 17 is a sensitive and specific marker for metanephric adenoma[ J]. Am J Surg Pathol, 2015, 39 (4) : 479-486. DOI: 10. 1097/PAS.
  • 4Rao Q, Xia QY, Wang ZY, et al. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours [ J ]. Histopathology, 2015,67 ( 1 ) : 121-129. DOI:10. llll/his. 12632.
  • 5Rao Q, Cheng L, Xia QY, et al. Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas): a clinicopathological study emphasizing extrarenal PEComas[J]. Histopathology, 2013,62(4) :642-650. DOI: 10. 1111/his. 12059.
  • 6Rao Q, Shen Q, Xia QY, et al. PSF/SFPQ is a very common gene fusion partner in TFF3 rearrangement-associated perivaseular epithelioid cell tumors (PEComas) and melanotie Xpl 1 translocationrenal cancers: clinicopathologic, immunohistochemical, and molecular characteristics suggesting classification as a distinct entity [ J ]. Am J Surg Pathol, 2015, 39 (9): 1181-1196. DOI: I0. 1097/PAS. 502.
  • 7Rao Q, Liu B, Cheng L, et al. Renal cell carcinomas with t (6; 11 )( p21 ;q12): a clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and uhrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization [J]. Am J Surg Pathol, 2012,36(9):1327-1338. DOI: 10. 1097/PAS. 0bO13e31825aafb5.
  • 8Rao Q, Williamson SR, Zhang S, et al. TFE3 break-apart FISH has a higher sensitivity for Xpl 1.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum[J]. Am J Surg Pathol, 2013,37 (6) : 804-815. DOI: 10. 1097/PAS. ObO13e31827e17eb.
  • 9Pflueger D, Sboner A, Storz M, et al. Identification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing [ J ]. Neoplasia, 2013,15 ( 11 ) : 1231-1240.
  • 10Cancer Genome Atlas Research Network; Linehan WM, Spellman PT, et al. Comprehensive molecular characterization of papillary renal-cell carcinoma[J]. N Engl J Med, 2016, 374 (2) : 135- 145. DOI: 10. 1056/NEJMoa1505917.

共引文献67

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部